Underwriters were given a 30-day option to purchase up to 1.74 million additional shares. ・Trevi is currently developing Haduvio, its treatment for chronic cough in patients with idiopathic pulmonary ...

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...

Cautionary Language Concerning Forward-Looking Statements ...

Backed by Novo Holdings and multiple other prominent investors, the biotech is developing what it’s positioning as superior ...

The Willard community is putting its support behind the city’s police chief, Tom McClain, as he underwent surgery for a ...

Avalyn Pharma is eyeing an IPO as the biotech seeks more funds to take its inhaled versions of approved drugs for lung ...

The FDA has approved Cipla's nintedanib capsules as a new generic version of Ofev for treating idiopathic pulmonary fibrosis ...

Shortness of breath, chronic coughing, or wheezing should not be ignored as they can be signs of a pulmonary condition. A ...

Dr Uta Hill joins the Clinical Excellence in Respiratory Care speaker line-up to discuss adult cystic fibrosis services and ...

After false starts and incremental gains, scientists crack the problem that made breathing impossible. Will answers come fast ...

Haunted by the cystic fibrosis patients he could not help, one Iowa doctor commits his life to understanding what is broken deep inside their cells.

Travis Corbitt knew he wasn't in the best shape, but he didn't understand why he felt like he could never catch his breath. He had been a police officer for more than 40 years, but chasing down ...